When we consider our goals in controlling equine herpesvirus-1, owners and veterinarians want to minimize respiratory disease, prevent abortion, and prevent myelitis (neurologic disease). We want to control viremia to decrease the amount of virus in the blood, and decrease the most serious effects of this infection

Paul Lunn, BVMS, MS, PhD, head of the Department of Clinical Sciences at Colorado State University, discussed immunity’s role in the neurologic form of equine herpesvirus-1 at a meeting hosted by the C.L. Davis Foundation and the American Association of Veterinary Laboratory Diagnosticians and sponsored by Fort Dodge Animal Health.

This free report provides the horse owner and caretaker with an overview of vaccine studies and controlling equine herpesvirus-1.